NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech.

Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech

US biotech company Moderna announced that it has begun trials of a booster dose of vaccine.

Washington:

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

The trials will involve a total of 600 adults -- half of whom have already received two doses of Moderna's Covid-19 vaccine at least six months ago, and half of whom have received two doses plus the previously authorized booster dose.

The booster specifically targeting Omicron will therefore be evaluated as both a third and a fourth dose.

The company also reported results on the efficacy against Omicron of the booster that has already been authorized.

It said that six months after the booster injection, the levels of neutralizing antibodies against Omicron were reduced by six times from the peak observed 29 days after the injection -- but remained detectable in all participants.

These data were obtained by studying the blood of 20 people who received the 50 microgram booster, half the amount of the first two injections.

"We are reassured by the antibody persistence against Omicron at six months after the currently authorized" booster, Moderna chief executive Stephane Bancel said in the statement.

"Nonetheless, given the long-term threat demonstrated by Omicron's immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study," Bancel continued.

Moderna's statement came the day after rivals Pfizer and BioNTech said they had begun enrollment for a clinical trial for an Omicron-specific vaccine.

Both vaccines are based on messenger RNA technology, which makes it relatively easy to update them to keep up with mutations specific to new variants.

Several countries, including the United States, have begun to see a decline in cases associated with the infection wave caused by Omicron, the most transmissible variant detected so far, but the number of infections worldwide continues to rise.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Останні новини
Manchester Arena attack: City remembers victims of suicide bomb five years on.

Manchester Arena attack: City remembers victims of suicide bomb five years on.

Manchester has been remembering the 22 victims of the arena bombing five years on from the terrorist attack. People paid their respects at events across the city to those who died in the 2017 suicide blast, which also left more than a thousand oth...

Nuclear weapons are ‘part of Putin’s arsenal’: Adm. Mike Mullen

Nuclear weapons are ‘part of Putin’s arsenal’: Adm. Mike Mullen

Martha Raddatz interviews former Joint Chiefs of Staff Chairman Adm. Mike Mullen on “This Week.”

US nuclear deterrent patrols the world’s oceans

US nuclear deterrent patrols the world’s oceans

Martha Raddatz reports on board a U.S. Navy ballistic missile submarine and explores how the most destructive warships ever built are helping keep Americans safe on “This Week.”

5 595

Miami mayor wants Elon Musk, Twitter to come to his 'free-market' city.

Miami mayor wants Elon Musk, Twitter to come to his 'free-market' city.

Miami Mayor Francis Suarez discusses the benefits of moving businesses to his city. #FoxNews Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news service deliverin...

1 5

We’re hoping for decision on boosters for kids under 5 in ‘next few weeks’: Jha l ABC News.

We’re hoping for decision on boosters for kids under 5 in ‘next few weeks’: Jha l ABC News.

Martha Raddatz interviews White House COVID-19 response coordinator Dr. Ashish Jha on “This Week.” SUBSCRIBE to ABC News: WATCH MORE on LIKE ABC News on FACEBOOK: FOLLOW ABC News on TWITTER: #ABCNews #ThisWeek #Vaccine #Booster

1 1

Zakaria: Democrats learned wrong lessons from Trump's 2016 victory.

Zakaria: Democrats learned wrong lessons from Trump's 2016 victory.

CNN's Fareed Zakaria argues that President Joe Biden's decision to leave in place some of his predecessor's policies harms the middle and working classes the most. #CNN #News